Literature DB >> 16768767

T4 gastric carcinoma: the benefit of non-curative resection.

Dong Y Kim1, Jae K Joo, Kyeung W Seo, Young K Park, Seong Y Ryu, Hyeong R Kim, Young J Kim, Shin K Kim.   

Abstract

BACKGROUND: The prognosis of patients with gastric carcinoma with invasion of the adjacent organs (T4 gastric carcinoma) is very poor. We evaluated the survival benefit of resection in this group of patients.
METHOD: We retrospectively reviewed the hospital records of 288 patients with T4 gastric carcinoma to compare the clinicopathological results in patients with curative resection (n = 95) with patients with non-curative resection (n = 193) during the period 1986-2000.
RESULTS: With a 33% curative resectability in patients with T4 gastric carcinoma, patients with tumour resection (curative and non-curative) had a significantly improved survival rate. The overall survival rate was higher for patients who underwent resection (11.6%) than for patients who were not resected (2.5%), regardless of curability (P < 0.001). Using Cox's proportional hazard regression model, lymph node invasion and curability were independent statistically significant prognostic parameters. The prognosis of patients with invasion to the peritoneum and adrenal glands was significantly poorer than that of patients in whom there was no such invasion. But, the number of organs invaded had no effect on patient survival.
CONCLUSIONS: Patients with T4 gastric carcinoma might be benefited from curative resection. The results also emphasize the improved survivorship of T4 gastric carcinoma patients with resection compared with those who did not undergo resection. Although curative resection cannot be undertaken in patients with T4 gastric carcinoma, we recommend performing resection in patients with locally advanced gastric carcinoma, regardless of curability.

Entities:  

Mesh:

Year:  2006        PMID: 16768767     DOI: 10.1111/j.1445-2197.2006.03751.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  11 in total

Review 1.  A systematic review of surgery for non-curative gastric cancer.

Authors:  Alyson L Mahar; Natalie G Coburn; Simron Singh; Calvin Law; Lucy K Helyer
Journal:  Gastric Cancer       Date:  2011-10-28       Impact factor: 7.370

Review 2.  Impact of clinicopathological parameters on survival after multiorgan resection among patients with T4 gastric carcinoma: a systematic review and meta-analysis.

Authors:  G Zu; T Zhang; W Li; Y Sun; X Zhang
Journal:  Clin Transl Oncol       Date:  2017-01-04       Impact factor: 3.405

3.  Prognostic Factors Affecting Survival After Multivisceral Resection in Patients with Clinical T4b Gastric Cancer.

Authors:  Kazuhito Mita; Hideto Ito; Toshio Katsube; Ayaka Tsuboi; Nobuyoshi Yamazaki; Hideki Asakawa; Takashi Hayashi; Keiichi Fujino
Journal:  J Gastrointest Surg       Date:  2017-09-22       Impact factor: 3.452

4.  Multivisceral Resection for Locally Advanced Gastric and Gastroesophageal Junction Cancers-11-Year Experience at a High-Volume North American Center.

Authors:  J C Molina; A Al-Hinai; A Gosseling-Tardif; P Bouchard; J Spicer; D Mulder; C L Mueller; L E Ferri
Journal:  J Gastrointest Surg       Date:  2018-04-16       Impact factor: 3.452

5.  Surgical management of gastric cancer: review and consideration for total care of the gastric cancer patient.

Authors:  Samielle Brancato; Thomas J Miner
Journal:  Curr Treat Options Gastroenterol       Date:  2008-04

6.  Multivisceral Resection for Locally Advanced Gastric Cancer.

Authors:  John G Aversa; Laurence P Diggs; Brendan L Hagerty; Dana A Dominguez; Philip H G Ituarte; Jonathan M Hernandez; Jeremy L Davis; Andrew M Blakely
Journal:  J Gastrointest Surg       Date:  2020-07-23       Impact factor: 3.267

7.  Extended multi-organ resection for cT4 gastric carcinoma: A retrospective analysis.

Authors:  Longbin Xiao; Mingzhe Li; Fengfeng Xu; Huishao Ye; Wenhui Wu; Shuo Long; Wenfeng Li; Yulong He
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

8.  Multivisceral Resection with Performing a Double Roux-en-Y Reconstruction for Advanced Gastric Cancer.

Authors:  Zijah Rifatbegovic; Zlatan Mehmedovic; Majda Mehmedovic; Jasmin Hasanovic; Amra Mestric
Journal:  Case Rep Surg       Date:  2015-11-24

9.  Histological complete response to a combined docetaxel/cisplatin/fluorouracil neoadjuvant chemotherapy for T4 stage gastric adenocarcinoma.

Authors:  Ming gao Guo; Qi Zheng; Jian zhong Di; Zhe Yang
Journal:  World J Surg Oncol       Date:  2014-05-19       Impact factor: 2.754

10.  Surgical outcomes and survival for T4 gastric cancer extending to the transverse colon.

Authors:  Gang-Cheng Wang; Ying-Jun Liu; Chong-Qing Gao; You-Cai Wang; Hui-Fang Lv; Bei-Bei Chen; Cai-Yun Nie; Xiao-Bing Chen; Su-Xia Luo
Journal:  Ann Transl Med       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.